Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS

Table of Contents

March 01, 2008; Volume 35,Issue 3
  • You have access
    Methotrexate therapy for psoriatic arthritis: reappraisal of an old remedy.
    Lesley Ann Saketkoo, Raquel Cuchacovich and Luis R Espinoza
    The Journal of Rheumatology March 1 2008, 35 (3) 369-371;
  • You have access
    Lessons from magnetic resonance imaging studies in rheumatoid arthritis.
    Mark Quinn
    The Journal of Rheumatology March 1 2008, 35 (3) 372-374;
  • You have access
    Infections, drugs, and rheumatoid arthritis. What have we learned?
    Jonathan S Coblyn
    The Journal of Rheumatology March 1 2008, 35 (3) 375-376;
  • You have access
    Diffuse idiopathic skeletal hyperostosis: time for a change.
    Reuven Mader
    The Journal of Rheumatology March 1 2008, 35 (3) 377-379;
  • You have access
    Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality.
    Cathrin Nikolaisen, Yngve Figenschau and Johannes C Nossent
    The Journal of Rheumatology March 1 2008, 35 (3) 380-386;
  • You have access
    The risk of hospitalized infection in patients with rheumatoid arthritis.
    Allison L Smitten, Hyon K Choi, Marc C Hochberg, Samy Suissa, Teresa A Simon, Marcia A Testa and K Arnold Chan
    The Journal of Rheumatology March 1 2008, 35 (3) 387-393;
  • You have access
    Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks.
    Maria Pilar Lisbona, Joan Maymo, Javier Perich, Miriam Almirall, Carolina Pérez-García and Jordi Carbonell
    The Journal of Rheumatology March 1 2008, 35 (3) 394-397;
  • You have access
    Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    György Kerekes, Zoltán Szekanecz, Henriett Dér, Zsuzsa Sándor, Gabriella Lakos, László Muszbek, István Csipö, Sándor Sipka, Ildikó Seres, György Paragh, János Kappelmayer, Edit Szomják, Katalin Veres, Gyula Szegedi, Yehuda Shoenfeld and Pál Soltész
    The Journal of Rheumatology March 1 2008, 35 (3) 398-406;
  • You have access
    Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
    Minoru Morishita, Masakazu Nagashima, Koichi Wauke, Hiroshi Takahashi and Kenji Takenouchi
    The Journal of Rheumatology March 1 2008, 35 (3) 407-413;
  • You have access
    Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
    Takashi Yamane, Akira Hashiramoto, Yasushi Tanaka, Ken Tsumiyama, Yasushi Miura, Kazuko Shiozawa, Kazuo Chihara and Shunichi Shiozawa
    The Journal of Rheumatology March 1 2008, 35 (3) 414-420;
  • You have access
    Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis.
    Döndü U Cansu, Timuçin Kalifoglu and Cengiz Korkmaz
    The Journal of Rheumatology March 1 2008, 35 (3) 421-424;
  • You have access
    IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
    Marijn Vis, Wouter H Bos, Gertjan Wolbink, Alexandre E Voskuyl, Jos W R Twisk, Rob Van de Stadt, Dörte Hamann, Ben A C Dijkmans and Willem F Lems
    The Journal of Rheumatology March 1 2008, 35 (3) 425-428;
  • You have access
    Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population.
    Marcos E Maldonado, Magdalena Perez, Judith Pignac-Kobinger, Emily Triana Marx, Elaine M Tozman, Eric L Greidinger and Robert W Hoffman
    The Journal of Rheumatology March 1 2008, 35 (3) 429-437;
  • You have access
    Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.
    Csilla András, Andrea Ponyi, Tamás Constantin, Zoltán Csiki, Eva Szekanecz, Peter Szodoray and Katalin Dankó
    The Journal of Rheumatology March 1 2008, 35 (3) 438-444;
  • You have access
    Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota.
    Floranne C Wilson, Steven R Ytterberg, Jennifer L St Sauver and Ann M Reed
    The Journal of Rheumatology March 1 2008, 35 (3) 445-447;
  • You have access
    Relapses in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: likely to begin with the same organ as initial onset.
    Min Chen, Feng Yu and Ming-Hui Zhao
    The Journal of Rheumatology March 1 2008, 35 (3) 448-450;
  • You have access
    Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Toshihide Hara, Fumihide Ogawa, Eiji Muroi, Kazuhiro Komura, Motoi Takenaka, Minoru Hasegawa, Manabu Fujimoto and Shinichi Sato
    The Journal of Rheumatology March 1 2008, 35 (3) 451-457;
  • You have access
    Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
    Vivien M Hsu, Abel E Moreyra, Alan C Wilson, Meir Shinnar, Daniel M Shindler, Julianne E Wilson, Ami Desai and James R Seibold
    The Journal of Rheumatology March 1 2008, 35 (3) 458-465;
  • You have access
    Does incorporation of aids and devices make a difference in the score of the health assessment questionnaire-disability index? Analysis from a scleroderma clinical trial.
    Dinesh Khanna, Philip J Clements, Arnold E Postlethwaite and Daniel E Furst
    The Journal of Rheumatology March 1 2008, 35 (3) 466-468;
  • You have access
    Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort.
    Vinod Chandran, Catherine T Schentag and Dafna D Gladman
    The Journal of Rheumatology March 1 2008, 35 (3) 469-471;
  • You have access
    Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.
    Philip S Helliwell, William J Taylor and CASPAR Study Group
    The Journal of Rheumatology March 1 2008, 35 (3) 472-476;
  • You have access
    Do we really need to evaluate entire cervical spines for squaring score in modified stoke ankylosing spondylitis spinal score?
    Tae-Jong Kim, Hee-Sun Kim, Kyung-Bin Joo, Sungjun Kim and Tae-Hwan Kim
    The Journal of Rheumatology March 1 2008, 35 (3) 477-479;
  • You have access
    A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27.
    Peter Schiellerup, Karen A Krogfelt and Henning Locht
    The Journal of Rheumatology March 1 2008, 35 (3) 480-487;
  • You have access
    Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
    John A Eisman, Roberto Civitelli, Silvano Adami, Edward Czerwinski, Chris Recknor, Richard Prince, Jean-Yves Reginster, Mone Zaidi, Dieter Felsenberg, Claire Hughes, Nicole Mairon, Daiva Masanauskaite, David M Reid, Pierre D Delmas and Robert R Recker
    The Journal of Rheumatology March 1 2008, 35 (3) 488-497;
  • You have access
    Gout in ambulatory care settings in the United States.
    Eswar Krishnan, Douglas Lienesch and C Kent Kwoh
    The Journal of Rheumatology March 1 2008, 35 (3) 498-501;
  • You have access
    A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
    Philip J Mease, I Jon Russell, Lesley M Arnold, Hana Florian, James P Young Jr, Susan A Martin and Uma Sharma
    The Journal of Rheumatology March 1 2008, 35 (3) 502-514;
  • You have access
    Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases.
    Shilpi Agarwal, Ramnath Misra and Amita Aggarwal
    The Journal of Rheumatology March 1 2008, 35 (3) 515-519;
  • You have access
    Indications for a disturbed peripheral T-cell homeostasis in juvenile idiopathic arthritis (JIA): absent expansion of CD28 T-cells and no decrease of naive T-cells in cytomegalovirus-positive patients with JIA.
    Martina Prelog, Nora Schwarzenbrunner, Michaela Sailer-Hoeck, Hannelore Kern, Christian Koppelstaetter, Reinhard Wurzner, Lothar Bernd Zimmerhackl and Juergen Brunner
    The Journal of Rheumatology March 1 2008, 35 (3) 520-527;
  • You have access
    Ossification of the posterior longitudinal ligament.
    Robert H Andres and Ralph Binggeli
    The Journal of Rheumatology March 1 2008, 35 (3) 528-529;
  • You have access
    Bone marrow histology in a patient with fever of unknown origin.
    Andreas Holbro, Stephan Dirnhofer, Philip Went, Alan Tyndall and Thomas Daikeler
    The Journal of Rheumatology March 1 2008, 35 (3) 530-531;
  • You have access
    New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept.
    In-Ho Song, Heiner Appel, Hildrun Haibel, Christoph Loddenkemper, Jurgen Braun, Joachin Sieper and Martin Rudwaleit
    The Journal of Rheumatology March 1 2008, 35 (3) 532-536;
  • You have access
    Alendronate-induced synovitis.
    David P Gwynne Jones, Ruth L Savage and John Highton
    The Journal of Rheumatology March 1 2008, 35 (3) 537-538;
  • You have access
    Systemic nocardiosis in a case of rheumatoid arthritis treated with tumor necrosis factor blockers.
    Daniel Wendling, Muhsen Murad, Sandra Mathieu, Eric Berger and Lucien Rumbach
    The Journal of Rheumatology March 1 2008, 35 (3) 539-542;
  • You have access
    Intrinsic muscle spasm of the hand: Bunnell's sign.
    Hajime Ishikawa
    The Journal of Rheumatology March 1 2008, 35 (3) 539;
  • You have access
    Nocardia infection with adalimumab in rheumatoid arthritis.
    Vijay Arun Doraiswamy
    The Journal of Rheumatology March 1 2008, 35 (3) 542-543;
  • You have access
    Prevalence of patello- and tibiofemoral osteoarthritis in Elva, Southern Estonia.
    Ann Tamm, Mare Lintrop, Karin Veske, Ulle Hansen and Agu Tamm
    The Journal of Rheumatology March 1 2008, 35 (3) 543-544;
  • You have access
    Rapid response of nail psoriasis to etanercept.
    Efstathios Rallis, Evgenia Stavropoulou, Dimitris Rigopoulos and Constantinos Verros
    The Journal of Rheumatology March 1 2008, 35 (3) 544-545;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 35, Issue 3
1 Mar 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • The Rheumatologist’s Role in COVID-19
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • COVID-19 and Rheumatic Diseases: It Is Time to Better Understand This Association
  • The Effect of HLA-B27 on Susceptibility and Severity of COVID-19
  • Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire